Loading…
Identified and characterized from C. tayuya root by Brazilian researchers. In vitro anti-inflammatory assays showed inhibition of NO production in LPS-stimulated macrophages at concentrations less cytotoxic than cucurbitacin B, suggesting a potentially wider therapeutic window. The glycoside form showed better oral bioavailability in preliminary animal pharmacokinetic studies.
Representative pattern: C₁₁H₁₄O₆
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.